Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
基本信息
- 批准号:10456888
- 负责人:
- 金额:$ 238.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAnimalsAntibioticsBindingBiochemicalBiologicalBiological AssayBiologyCellsChemistryCommunicationCommunity DevelopmentsComplexCryoelectron MicroscopyDevelopmentDrug TargetingEnzymesGeneticGenomicsGenus MycobacteriumGoalsKnowledgeMacromolecular ComplexesMediatingMembraneMembrane ProteinsMembrane Transport ProteinsMetabolicMultienzyme ComplexesMycobacterium tuberculosisMycobacterium tuberculosis complexNational Institute of Allergy and Infectious DiseaseOrganismProteinsResearchResourcesRibosomesRoleSiderophoresSpecificityStructureSupervisionTranslationsVirulenceWorkbasechemical geneticsdrug developmentdrug discoveryflexibilitygenetic informationimprovedinhibitorinnovative technologiesinterdisciplinary approachmycobacterialnew therapeutic targetnovelpreclinical developmentprogramsprotein structuresmall moleculesmall molecule inhibitorstructural biologystructural genomicstuberculosis drugs
项目摘要
Project Summary – Overall
The TB Structural Genomics Consortium (TBSGC) is a collaborative research group that has
studied TB’s causative organism, Mycobacterium tuberculosis (Mtb), for the past 15 years. Over
the years we have focused our goals to concentrate on proteins that are drug targets for novel
antibiotics, and proteins whose structure might contribute to our knowledge of vulnerabilities in
Mtb. We also supplemented our structural work with both chemistry and genetics to validate our
targets, to obtain and optimize protein inhibitors, and to determine their underlying biological roles
within Mtb. Our multidisciplinary approach has allowed us to add considerable knowledge to
mycobacterial structures, and to leverage this information to inform drug development.
Significantly, results of the last TBSGC cycle has led to a novel anti-TB drug that is in late pre-
clinical development along with others compounds that have been adopted by anti-TB drug
developers.
In this TBSGC renewal, we propose to incorporate new innovative technologies, including
membrane protein structures and cryo-EM, to strengthen our commitment to TB drug
development. We will leverage structure determination to both understand function and identify
potential small molecule inhibitors. The fundamental goal of this project is to accelerate TB drug
discovery by understanding essential functions of the mycobacterial cell and providing validated
targets and inhibitors to our partners in the TB drug development community.
项目摘要--总体
结核病结构基因组学联盟(TBSGC)是一个合作研究组织,它拥有
在过去的15年里,研究了结核病的病原体--结核分枝杆菌(Mtb)。完毕
多年来,我们一直将目标集中在作为新药靶点的蛋白质上
抗生素和蛋白质,它们的结构可能有助于我们了解
山地车。我们还用化学和遗传学补充了我们的结构工作,以验证我们的
靶点,以获得和优化蛋白质抑制剂,并确定其潜在的生物学作用
在MTB内。我们的多学科方法使我们能够增加大量的知识
分枝杆菌结构,并利用这些信息来为药物开发提供信息。
值得注意的是,上一次TBSGC周期的结果导致了一种新的抗结核病药物,该药物处于晚期
抗结核药物采用的其他化合物的临床进展
开发商。
在此次TBSGC续期中,我们建议采用新的创新技术,包括
膜蛋白结构和冷冻-EM,以加强我们对结核病药物的承诺
发展。我们将利用结构决定来理解功能和确定
潜在的小分子抑制剂。这个项目的基本目标是加速治疗结核病的药物
通过了解分枝杆菌细胞的基本功能并提供经过验证的
向我们在结核病药物开发界的合作伙伴提供靶标和抑制剂。
项目成果
期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology.
利用结构生物学发现结核分枝杆菌治疗的进展。
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Chim,Nicholas;Owens,CedricP;Contreras,Heidi;Goulding,CeliaW
- 通讯作者:Goulding,CeliaW
Structural and biochemical analyses of Mycobacterium tuberculosis N-acetylmuramyl-L-alanine amidase Rv3717 point to a role in peptidoglycan fragment recycling.
结核分枝杆菌 N-乙酰胞壁酰-L-丙氨酸酰胺酶 Rv3717 的结构和生化分析表明其在肽聚糖片段回收中发挥作用。
- DOI:10.1074/jbc.m113.510792
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Prigozhin,DaniilM;Mavrici,Daniela;Huizar,JohnP;Vansell,HilaryJ;Alber,Tom
- 通讯作者:Alber,Tom
Covalent Inactivation of Mycobacterium tuberculosis Isocitrate Lyase by cis-2,3-Epoxy-Succinic Acid.
顺式 2,3-环氧琥珀酸共价灭活结核分枝杆菌异柠檬酸裂解酶。
- DOI:10.1021/acschembio.0c00740
- 发表时间:2021
- 期刊:
- 影响因子:4
- 作者:Pham,TrucViet;Mellott,DrakeM;Moghadamchargari,Zahra;Chen,Kevin;Krieger,Inna;Laganowsky,Arthur;Sacchettini,JamesC;Meek,ThomasD
- 通讯作者:Meek,ThomasD
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target.
- DOI:10.1021/acs.jmedchem.1c01586
- 发表时间:2022-01-13
- 期刊:
- 影响因子:7.3
- 作者:Wilson C;Ray P;Zuccotto F;Hernandez J;Aggarwal A;Mackenzie C;Caldwell N;Taylor M;Huggett M;Mathieson M;Murugesan D;Smith A;Davis S;Cocco M;Parai MK;Acharya A;Tamaki F;Scullion P;Epemolu O;Riley J;Stojanovski L;Lopez-Román EM;Torres-Gómez PA;Toledo AM;Guijarro-Lopez L;Camino I;Engelhart CA;Schnappinger D;Massoudi LM;Lenaerts A;Robertson GT;Walpole C;Matthews D;Floyd D;Sacchettini JC;Read KD;Encinas L;Bates RH;Green SR;Wyatt PG
- 通讯作者:Wyatt PG
Mycobacterial recombineering.
- DOI:10.1007/978-1-4939-2450-9_10
- 发表时间:2015-01-01
- 期刊:
- 影响因子:0
- 作者:Murphy, Kenan C;Papavinasasundaram, Kadamba;Sassetti, Christopher M
- 通讯作者:Sassetti, Christopher M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES C SACCHETTINI其他文献
JAMES C SACCHETTINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES C SACCHETTINI', 18)}}的其他基金
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
基于结构的微生物关键漏洞发现
- 批准号:
8711232 - 财政年份:2012
- 资助金额:
$ 238.76万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
基于结构的微生物关键漏洞发现
- 批准号:
8534693 - 财政年份:2012
- 资助金额:
$ 238.76万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
9755323 - 财政年份:2012
- 资助金额:
$ 238.76万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
10242858 - 财政年份:2012
- 资助金额:
$ 238.76万 - 项目类别:
Admin Core TAMU (Sacchettini) Lead
管理核心 TAMU (Sacchettini) 负责人
- 批准号:
10456889 - 财政年份:2012
- 资助金额:
$ 238.76万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 238.76万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 238.76万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 238.76万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 238.76万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 238.76万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 238.76万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 238.76万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 238.76万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 238.76万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 238.76万 - 项目类别:
Training Grant